MoneyWorks4Me

FDC - Quaterly Results

09 Feb 2023 Evaluate
The revenue zoomed 19.20% to Rs. 4066.06 millions for the quarter ended December 2022 as compared to Rs. 3411.11 millions during the corresponding quarter last year.Profit saw a slight increase of 24.80%to Rs. 394.31  millions from Rs. 315.95 millions.Operating profit for the quarter ended December 2022 rose to 652.83 millions as compared to 565.76 millions of corresponding quarter ended December 2021.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202212 202112 % Var 202212 202112 % Var 202203 202103 % Var
Sales 4066.06 3411.11 19.20 13458.35 11823.58 13.83 15189.65 13254.49 14.60
Other Income 187.63 131.22 42.99 667.93 671.32 -0.50 787.34 971.46 -18.95
PBIDT 652.83 565.76 15.39 2444.61 2967.71 -17.63 3255.80 4214.76 -22.75
Interest 11.84 8.44 40.28 28.91 23.61 22.45 30.48 34.02 -10.41
PBDT 640.99 557.32 15.01 2415.70 2944.10 -17.95 3225.32 4180.74 -22.85
Depreciation 98.12 89.87 9.18 290.67 279.18 4.12 370.81 376.23 -1.44
PBT 542.87 467.45 16.13 2125.03 2664.92 -20.26 2854.51 3804.51 -24.97
TAX 148.56 151.50 -1.94 487.77 612.37 -20.35 658.15 859.61 -23.44
Deferred Tax 32.56 6.50 400.92 -54.23 -33.63 61.25 -21.85 14.45 -251.21
PAT 394.31 315.95 24.80 1637.26 2052.55 -20.23 2196.36 2944.90 -25.42
Equity 165.91 168.81 -1.72 165.91 168.81 -1.72 168.81 168.81 0.00
PBIDTM(%) 16.06 16.59 -3.20 18.16 25.10 -27.63 21.43 31.80 -32.59
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..